American Century Companies’s Twist Bioscience TWST Stock Holding History

American Century Companies's TWST Position: Q1 2026 in Review

American Century Companies reduced its Twist Bioscience (TWST) stake by 96% in Q1 2026, selling an estimated $37.1M and leaving 37,838 shares worth $1.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2156.

American Century Companies first reported a position in TWST in Q2 2023 and has held it in 12 quarters since. The position peaked at $35.1M in Q4 2024. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

• American Century Companies held 37,838 shares of Twist Bioscience worth $1.8M as of Q1 2026.
• American Century Companies sold 827,796 Twist Bioscience shares in Q1 2026, an estimated $37.1M.
• Twist Bioscience made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2156 holding.
• American Century Companies first reported a position in Twist Bioscience in Q2 2023 and has held it in 12 quarters since.
• American Century Companies's Twist Bioscience position peaked at $35.1M in Q4 2024.
• 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.